Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Salmeterol”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00118716
What this trial is testing

A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise

Who this might be right for
BronchospasmActivity/Exercise Induced Bronchospasm
GlaxoSmithKline 248
Large-scale testing (Phase 3)Study completedNCT01817764
What this trial is testing

Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 707
Post-approval studies (Phase 4)Study completedNCT00115492
What this trial is testing

Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 797
Post-approval studies (Phase 4)Ended earlyNCT00346749
What this trial is testing

ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 180
Post-approval studies (Phase 4)UnknownNCT01361984
What this trial is testing

Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography

Who this might be right for
Chronic Obstructive Pulmonary DiseaseCOPDEmphysema+1 more
University of California, Los Angeles 20
Post-approval studies (Phase 4)Study completedNCT01475721
What this trial is testing

SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.

Who this might be right for
Asthma
GlaxoSmithKline 11,751
Early research (Phase 1)Study completedNCT02254226
What this trial is testing

Pharmacokinetics of Salmeterol (Serevent®) After Inhalation With Metered Dose Inhaler (MDI) and Diskus® in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 26
Early research (Phase 1)Study completedNCT04462822
What this trial is testing

A Pilot Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Who this might be right for
Bioequivalence
Respirent Pharmaceuticals Co Ltd. 14
Large-scale testing (Phase 3)Study completedNCT01089127
What this trial is testing

Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals 552
Post-approval studies (Phase 4)Study completedNCT00404261
What this trial is testing

Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).

Who this might be right for
Asthma
GlaxoSmithKline 132
Post-approval studies (Phase 4)Study completedNCT00784550
What this trial is testing

A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 342
Large-scale testing (Phase 3)WithdrawnNCT02496715
What this trial is testing

Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics

Who this might be right for
Asthma
Actavis Inc.
Testing effectiveness (Phase 2)Study completedNCT01248975
What this trial is testing

Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma

Who this might be right for
Asthma
GlaxoSmithKline 145
Large-scale testing (Phase 3)Study completedNCT00127166
What this trial is testing

Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)

Who this might be right for
Exercise Induced Asthma
Organon and Co 154
Large-scale testing (Phase 3)Study completedNCT00328718
What this trial is testing

Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets

Who this might be right for
Asthma
GlaxoSmithKline 526
Early research (Phase 1)Study completedNCT03238482
What this trial is testing

Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)

Who this might be right for
Asthma
Orion Corporation, Orion Pharma 64
Large-scale testing (Phase 3)Study completedNCT01772147
What this trial is testing

Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder (62.5 or 125mcg) Once-daily Over 12 Weeks.

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 608
Large-scale testing (Phase 3)Study completedNCT02139644
What this trial is testing

Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma

Who this might be right for
Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 787
Not applicableStudy completedNCT02757209
What this trial is testing

Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD

Who this might be right for
AsthmaCOPD
Consorzio Futuro in Ricerca 84
Early research (Phase 1)WithdrawnNCT02218762
What this trial is testing

A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® Inhaler

Who this might be right for
Asthma
GlaxoSmithKline
Next Page